Targeting Opioid and Neurokinin-1 Receptors to Treat Alcoholism

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|18|28|4321-4334

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.18, Iss.28, 2011-10, pp. : 4321-4334

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New Approaches in the Treatment of Overactive Bladder: Targeting Adrenergic Receptors and Neurokinin Receptors

By  

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 3, Iss. 1, 2003-03 ,pp. : 43-47

Bentham Science Publishers

Access to resources Recommend Favorite

LY 686017, a selective neurokinin 1 receptor antagonist, has demonstrated potential for alcoholism.

By  

Inpharma, Vol. 1, Iss. 1636, 2008-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Emerging drugs to treat alcoholism

By Soyka Michael   Rösner Susanne  

Expert Opinion on Emerging Drugs, Vol. 15, Iss. 4, 2010-12 ,pp. : 695-711

Informa Healthcare

Access to resources Recommend Favorite

Commentary [Targeting Opioid Receptors: A New Treatment for Brain Disorders]

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 9, Iss. 2, 2010-04 ,pp. : 128-128

Bentham Science Publishers

Access to resources Recommend Favorite

Opioid-Like Effects of the Neurokinin 1 Antagonist Aprepitant in Patients Maintained on and Briefly Withdrawn from Methadone

By Jones Jermaine D.  

The American Journal of Drug and Alcohol Abuse, Vol. 39, Iss. 2, 2013-03 ,pp. : 86-91

Informa Healthcare

Access to resources Recommend Favorite